CDNA סך כל נכסי החברה CareDx

CareDx, Inc (CDNA) generates revenue through innovative transplantology methods, offering high-margin genomic research for organ monitoring. The current development vector focuses on integrating diagnostic systems into insurance protocols to expand the market. The current price action of total assets is 488.60. Financial results are based on the laboratory analysis of heart, lung, and kidney rejection risks using molecular technologies.

Total assets reflect the aggregate volume of resources for CareDx, Inc (CDNA), calculated reverse-engineered through return on assets (ROA) to evaluate capital efficiency. The trend in total asset value demonstrates the business's capital intensity, where costs for strict compliance with environmental regulations regarding bio-waste disposal and the digitalization of reporting directly impact the balance sheet structure and the company's growth rates.